Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Pilot Study of Single-port Robot-assisted Nipple-sparing Mastectomy

NCT05448963 · Chang Gung Memorial Hospital · Updated 25 April 2023

What is being tested
da Vinci SPⓇ Single-port System
For
Nipple-sparing Mastectomy; Prophylactic Mastectomy; Breast Cancer; BRCA1 Mutation; BRCA2 Mutation
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 20 years to 80 years. About 30 people. The full rules are on the registry page.
Where
Taiwan
When
Starts or started 30 July 2022, ends 1 Aug 2023. Registered 8 July 2022.
Results
None posted yet.

In the researchers' words

Nipple-sparing mastectomy (NSM) is indicated for breast cancer requiring total mastectomy and without nipple involvement by cancer. Robot-assisted mastectomy enables removal of the whole breast tissue with well-preserved breast skin envelope through a single longitudinal incision in the anterior axillary line at the nipple areolar level. The next-generation robot, da Vinci SP system, is single-armed, equipped with multiple flexible instruments and camera, which is likely to improve the efficacy of robotic mastectomy. The investigator's scope of this study is to establish the feasibility and safety of SP-applied NSM through this single-armed pilot trial. Participants with breast cancer indicated for nipple-sparing mastectomy or candidates of prophylactic mastectomy carrying germline pathogenic or likely pathogenic BRCA1/2 mutations are recruited to receive SP-assisted unilateral or bilateral NSMs. Immediate breast reconstruction is followed according to the mode of the plastic surgeon's clinical decision. The primary endpoint is technical feasibility, and the secondary endpoint is safety and patient-reported outcome.
ClinicalTrials.gov, NCT05448963

Sites

  • Chang Gung Memeorial Hospital, Linkou Medical CenterTaoyuan, Taiwan